General MedicationsINJECTIONGeneric
COACTIN
AMDINOCILLIN
Standard Dose
500MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview COACTIN is listed in Drugs@FDA under application 050565 (NDA).
Marketing status: Discontinued Active ingredient AMDINOCILLIN Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor ROCHE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview COACTIN is listed in Drugs@FDA under application 050565 (NDA). Marketing status: Discontinued Active ingredient AMDINOCILLIN Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor ROCHE Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.